Thomas Ciulla
2021
In 2021, Thomas Ciulla earned a total compensation of $1.8M as Chief Medical Officer and Chief Development Officer at Clearside Biomedical, a 172% increase compared to previous year.
Compensation breakdown
| Bonus | $14,500 |
|---|---|
| Non-Equity Incentive Plan | $149,608 |
| Option Awards | $822,123 |
| Salary | $412,000 |
| Stock Awards | $413,531 |
| Other | $13,658 |
| Total | $1,825,420 |
Ciulla received $822.1K in option awards, accounting for 45% of the total pay in 2021.
Ciulla also received $14.5K in bonus, $149.6K in non-equity incentive plan, $412K in salary, $413.5K in stock awards and $13.7K in other compensation.
Rankings
In 2021, Thomas Ciulla's compensation ranked 6,394th out of 12,415 executives tracked by ExecPay. In other words, Ciulla earned more than 48.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,394 out of 12,415 | 49th |
Division Manufacturing | 2,730 out of 5,505 | 50th |
Major group Chemicals And Allied Products | 1,203 out of 2,375 | 49th |
Industry group Drugs | 1,071 out of 2,096 | 49th |
Industry Pharmaceutical Preparations | 774 out of 1,546 | 50th |
Source: SEC filing on April 29, 2022.
Ciulla's colleagues
We found two more compensation records of executives who worked with Thomas Ciulla at Clearside Biomedical in 2021.